A novel series of potent gamma-secretase inhibitors based on a benzobicyclo[4.2.1]nonane core.
A new series of gamma-secretase inhibitors was developed from an in-house screening hit based on a benzobicyclo[4.2.1]nonane core. Lead optimisation studies led to the development of a series of potent inhibitors and in vivo efficacy was demonstrated.